Genetic research is advancing rapidly. One important area for the application of the results
from this work is personalized health. These are treatments and preventive interventions …

Responsibility and professionalism are increasingly issues of concern for professional
associations, employers and educators alike. When bad things happen, professionals are …

This chapter reviews social science contributions to the analysis of genomic platforms
deployed in bio-clinical activities. It focuses on so-called next generation sequencing …

This article draws on 2 years' worth of ethnographic observation of team meetings to explore
decision‐making in an NHS clinical genomics service. The focus of discussions was on …

Pharmacogenetic tests provide genetic data to tailor drug treatment and were widely
predicted to be one of the first fruits of the Human Genome Project. In the mid‐2000s, the US …

Social innovation initiatives in the pharmaceutical field seek alternative, collaborative ways
to address problems with availability and affordability of medicines. However, these …

This paper analyses the politics of regulatory expansion within the diagnostics sector. Since
1990, an informal, clinician-led process of diagnostic innovation within the UK NHS has …

As pharmacogenomics and personalized medicine progressively build knowledge of the
genetic and genomic determinants of person-to-person and population differences in drug …

对2010-2017 年技术标准规制领域的文献进行了系统汇集, 整理, 分类和分析. 首先,
基于规制主体视角, 将技术标准形成过程中的规制划分为政府规制(G), 联盟/协会规制(A) …

This chapter describes how the regulatory frameworks for diagnostic technologies are
changing, in part as a response to technological advances in personalised medicine. It …